Lack of association between KIR and HLA-C type and susceptibility to idiopathic bronchiectasis.
暂无分享,去创建一个
J. Lordan | P. Corris | D. Middleton | S. Bourke | S. Worthy | C. Ward | A. De Soyza | M. McDonnell | R. Rutherford | R. Rutherford | A. D. Soyza | G. A. Anwar | G. Afolabi | P. Middleton | James Lawrence Lordan | Sylvia Worthy | Chris Ward | Melissa J. McDonnell | P. Corris | P. G. Middleton
[1] J. Lordan,et al. Phenotyping adults with non-cystic fibrosis bronchiectasis: a prospective observational cohort study. , 2013, Respiratory medicine.
[2] Kathryn J. Quigley,et al. Immune mechanisms and the impact of the disrupted lung microbiome in chronic bacterial lung infection and bronchiectasis , 2013, Clinical and experimental immunology.
[3] Jeremy S. Brown,et al. Research priorities in bronchiectasis , 2012, Thorax.
[4] D. Altmann,et al. Immune regulation in idiopathic bronchiectasis , 2012, Annals of the New York Academy of Sciences.
[5] Paolo Vineis,et al. STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. , 2011, Mutagenesis.
[6] J. Ioannidis,et al. STrengthening the reporting of OBservational studies in Epidemiology—Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement , 2011, European Journal of Epidemiology.
[7] G. Westergren-Thorsson,et al. Infection and remodelling: a 21st century model of bronchiectasis? , 2011, European Respiratory Journal.
[8] S. Khakoo,et al. KIR/HLA Interactions and Pathogen Immunity , 2011, Journal of biomedicine & biotechnology.
[9] M. Carrington,et al. HLA/KIR restraint of HIV: surviving the fittest. , 2011, Annual review of immunology.
[10] S Tonks,et al. Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA. , 2010, Tissue antigens.
[11] Derek Middleton,et al. The extensive polymorphism of KIR genes , 2010, Immunology.
[12] M. Carrington,et al. Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex , 2009, Human molecular genetics.
[13] F. Culley. Natural killer cells in infection and inflammation of the lung , 2009, Immunology.
[14] P. Gourraud,et al. Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia. , 2009, Tissue antigens.
[15] S. Khakoo,et al. Natural killer cells: integrating diversity with function , 2009, Immunology.
[16] Smita Kulkarni,et al. The Yin and Yang of HLA and KIR in human disease. , 2008, Seminars in immunology.
[17] D. Hassett,et al. NKG2D Is Critical for NK Cell Activation in Host Defense against Pseudomonas aeruginosa Respiratory Infection1 , 2008, The Journal of Immunology.
[18] D. Altmann,et al. Human leucocyte antigen class II association in idiopathic bronchiectasis, a disease of chronic lung infection, implicates a role for adaptive immunity , 2008, Clinical and experimental immunology.
[19] D. Altmann,et al. Natural killer cells, killer immunoglobulin‐like receptors and human leucocyte antigen class I in disease , 2007, Clinical and experimental immunology.
[20] D. Middleton,et al. Study of KIR genes in tuberculosis patients. , 2006, Tissue antigens.
[21] M. Carrington,et al. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. , 2006, Annual review of genomics and human genetics.
[22] J. Trowsdale,et al. HLA-C and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis. , 2006, American journal of respiratory and critical care medicine.
[23] P. Parham,et al. KIR3DL1 Polymorphisms That Affect NK Cell Inhibition by HLA-Bw4 Ligand1 , 2005, The Journal of Immunology.
[24] B. Koeleman,et al. KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. , 2003, Diabetes.
[25] Michael J. Wilson,et al. Cutting Edge: Susceptibility to Psoriatic Arthritis: Influence of Activating Killer Ig-Like Receptor Genes in the Absence of Specific HLA-C Alleles1 , 2002, The Journal of Immunology.
[26] D. Middleton,et al. Molecular diversity of the HLA-C gene identified in a caucasian population. , 2002, Human immunology.
[27] D Middleton,et al. Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires. , 2000, Tissue antigens.
[28] D Middleton,et al. New allele frequency database: http://www.allelefrequencies.net. , 2003, Tissue antigens.
[29] Derek Middleton,et al. New allele frequency database: www.allelefrequencies.net , 2003 .